Evidence map›Paper›PMID 33643507›Full record

ArticleJournal of hematology2021

Histologic Transformation in an Untreated Waldenstrom's Macroglobulinemia After 14 Years: Case Report and Review of the Literature.

Elizabeth B Elimimian, Nadeem Bilani, Maria J Diacovo, Skirmante Sirvaitis, Chieh Lin Fu

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elizabeth B ElimimianDepartment of Hematology-Oncology, Maroone Cancer Center, Cleveland Clinic, Florida 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA.
Nadeem BilaniDepartment of Hematology-Oncology, Maroone Cancer Center, Cleveland Clinic, Florida 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA.
Maria J DiacovoDepartment of Hematology-Oncology, Maroone Cancer Center, Cleveland Clinic, Florida 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA.
Skirmante SirvaitisMercy Health, Internal Medicine Residency Program, Rockford, IL 61114, USA.
Chieh Lin FuDepartment of Hematology-Oncology, Maroone Cancer Center, Cleveland Clinic, Florida 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA.
Cleveland Clinic Florida · USMercy Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Waldenstrom's macroglobulinemia (WM) is an indolent B-cell non-Hodgkin lymphoma characterized by lymphoplasmacytic histology in the bone marrow with monoclonal IgM. Median survival can be in excess of 10 years. The 5-year cumulative incidence of death is low at about 10%. One-third of all-cause specific mortality is due to the lymphoma for which histologic transformation (HT) is rare. Here we present a case of a 60-year-old man with longstanding untreated WM, presenting with minimally symptomatic transformation to diffuse large B-cell lymphoma (DLBCL), with an accompanying review of the literature. Transformed WM, diagnosed greater than 5 years, has a reported survival period of 8 - 9 months. This case highlights that after a decade of continued stability in WM, not requiring treatment, an acute change in laboratory data with minimally progressive IgM levels, in the absence of B symptoms and clinical findings, may be the harbinger of transformation and at the time of diagnosis can have a rapidly deteriorating clinical course. In this case, the tripling of the lactate dehydrogenase (LDH) as the primary drastic change demonstrates the importance of the rapid increase in LDH as a singly reliable marker for HT. Late transformation has been borne out as a negative variable as the generally indolent course of WM is curtailed with the poor outcome in HT. Although MYD88 wildtype is a possible predictive factor for transformation, it is unclear if late transformation is clonally or non-clonally related and further molecular investigation is needed.

Indexed as

Diffuse large B-cell lymphomaHistologic transformationNon-Hodgkin lymphomaWaldenstrom’s macroglobulinemia

Identifiers

PMID33643507
PMCPMC7891909
OpenAlexW3128585404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.